Growth Metrics

Humana (HUM) EPS (Weighted Average and Diluted) (2016 - 2025)

Humana has reported EPS (Weighted Average and Diluted) over the past 17 years, most recently at -$6.59 for Q4 2025.

  • Quarterly results put EPS (Weighted Average and Diluted) at -$6.59 for Q4 2025, down 14.81% from a year ago — trailing twelve months through Dec 2025 was $9.84 (down 1.3% YoY), and the annual figure for FY2025 was $9.84, down 1.4%.
  • EPS (Weighted Average and Diluted) for Q4 2025 was -$6.59 at Humana, down from $1.62 in the prior quarter.
  • Over the last five years, EPS (Weighted Average and Diluted) for HUM hit a ceiling of $11.84 in Q3 2021 and a floor of -$6.59 in Q4 2025.
  • Median EPS (Weighted Average and Diluted) over the past 5 years was $5.55 (2024), compared with a mean of $4.23.
  • Biggest five-year swings in EPS (Weighted Average and Diluted): skyrocketed 95.15% in 2021 and later crashed 5225.0% in 2023.
  • Humana's EPS (Weighted Average and Diluted) stood at -$0.1 in 2021, then rose by 20.0% to -$0.08 in 2022, then crashed by 5225.0% to -$4.26 in 2023, then crashed by 34.74% to -$5.74 in 2024, then decreased by 14.81% to -$6.59 in 2025.
  • The last three reported values for EPS (Weighted Average and Diluted) were -$6.59 (Q4 2025), $1.62 (Q3 2025), and $4.51 (Q2 2025) per Business Quant data.